Leverone Jason A. 4
4 · MIRAGEN THERAPEUTICS, INC. · Filed Mar 17, 2020
Insider Transaction Report
Form 4
Leverone Jason A.
CFO, Treasurer & Secretary
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-03-13−11,249→ 0 totalExercise: $0.57Exp: 2020-03-15→ Common Stock (11,249 underlying) - Exercise/Conversion
Common Stock
2020-03-13$0.57/sh+11,249$6,412→ 48,829 total
Footnotes (2)
- [F1]Includes 1,250 shares acquired under the Miragen Therapeutics, Inc. 2015 Employee Stock Purchase Plan on February 21, 2020.
- [F2]The option is fully vested and exercisable. The option expires ten years after the date of grant.